(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(0.35%) $83.86
(-3.36%) $1.583
(0.19%) $2 347.00
(0.68%) $27.54
(1.05%) $930.20
(0.10%) $0.933
(0.15%) $10.97
(0.08%) $0.800
(0.01%) $92.18
Quarter results today
(bmo 2024-04-26)
Expected move: +/- 0.00%
0.00% IDR 1 430.00
Live Chart Being Loaded With Signals
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic...
Stats | |
---|---|
Today's Volume | 2.33M |
Average Volume | 37.52M |
Market Cap | 66 145.54B |
EPS | IDR0 ( 2024-04-10 ) |
Last Dividend | IDR0 ( N/A ) |
Next Dividend | IDR0 ( N/A ) |
P/E | 23.93 |
ATR14 | IDR3.32 (0.23%) |
Volume Correlation
PT Kalbe Farma Tbk. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PT Kalbe Farma Tbk. Correlation - Currency/Commodity
PT Kalbe Farma Tbk. Financials
Annual | 2023 |
Revenue: | IDR30 449.13B |
Gross Profit: | IDR11 438.05B (37.56 %) |
EPS: | IDR59.81 |
Q4 | 2023 |
Revenue: | IDR7 888.13B |
Gross Profit: | IDR2 819.98B (35.75 %) |
EPS: | IDR15.17 |
Q3 | 2023 |
Revenue: | IDR7 382.08B |
Gross Profit: | IDR2 731.20B (37.00 %) |
EPS: | IDR11.59 |
Q2 | 2023 |
Revenue: | IDR7 309.77B |
Gross Profit: | IDR2 956.35B (40.44 %) |
EPS: | IDR14.56 |
Financial Reports:
No articles found.
PT Kalbe Farma Tbk.
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. The company also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, it offers contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products, as well as operates Mitrasana Clinics, a health care service. Further, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators